Subgroup analyses demonstrated that EGFR overexpression was related to poor DFS in cervical cancer patients who were treated with chemoradiation (HR: 1.69, 95% CI: 1.32–2.15) and surgery (HR: 2.02, 95% CI: 1.37–2.96). Here, EGFR is linked to cervical cancer.